nach oben

Current Psychiatry Reports

Erschienen in:

01.01.2013 | Genetic Disorders (JF Cubells and EB Binder, Section Editors)

The Genetics of Autism Spectrum Disorders – A Guide for Clinicians

verfasst von: Karsten M. Heil, Christian P. Schaaf

Erschienen in: Current Psychiatry Reports | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Recent advances in genetic testing technology have made chromosome microarray analysis (CMA) a first-tier clinical diagnostic test for Autism Spectrum Disorders (ASDs). Two main types of microarrays are available, single nucleotide polymorphism (SNP) arrays and array comparative genomic hybridization (aCGH), each with its own advantages and disadvantages in ASDs testing. Rare genetic variants, and copy number variants (CNVs) in particular, have been shown to play a major role in ASDs. More than 200 autism susceptibility genes have been identified to date, and complex patterns of inheritance, such as oligogenic heterozygosity, appear to contribute to the etiopathogenesis of ASDs. Incomplete penetrance and variable expressivity represent particular challenges in the interpretation of CMA testing of autistic individuals. This review aims to provide an overview of autism genetics for the practicing physician and gives hands-on advice on how to follow-up on abnormal CMA findings in individuals with neuropsychiatric disorders.

Smalley SL, Asarnow RF, Spence MA. Autism and genetics. Arch Gen Psychiatry. 1988;45:953–61.PubMedCrossRef

• Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet. 2010;86(5):749–64. A meta-analysis of chromosome microarray testing in individuals with intellectual disability, congenital anomalies, and autism spectrum disorders.PubMedCrossRef

El-Fishawy P, State MW. The genetics of autism: key issues, recent findings, and clinical implications. Psychiatr Clin North Am. 2010;33(1):83–105.PubMedCrossRef

Bassett AS, McDonald-McGinn DM, Devriendt K, et al. Practical guidelines for managing patients with 22q11.2 deletion syndrome. J Pediatr. 2011;159(2):332–9.PubMedCrossRef

Bayani J, Squire JA. Traditional banding of chromosomes for cytogenetic analysis. Curr Protoc Cell Biol. 2004. Chapter 22:Unit 22.3.

Schaaf CP, Wisznewska J, Beaudet AL. Copy Number and SNP arrays in clinical diagnostics. Annu Rev Genomics Hum Genet. 2011;12:25–51.PubMedCrossRef

National Center for Biotechnology Information (NCBI): NCBI dbSNP build 137 for Human. Available at http://www.ncbi.nlm.nih.gov/mailman/pipermail/dbsnp-announce/2012q2/000123.html. Accessed July 2012.

National Center for Biotechnology Information (NCBI): Human genome assembly information for GRCh37.p9. Available at http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/human/data/index.shtml. Accessed July 2012.

Lubitz RJ, Komaromy M, Crawford B, et al. Development and pilot evaluation of novel genetic educational materials designed for an underserved patient population. Genet Test. 2007;11(3):276–90.PubMedCrossRef

10.

Schaaf CP, Scott DA, Wiszniewska J, Beaudet AL. Identification of incestuous parental relationships by SNP-based DNA microarrays. Lancet. 2011;377(9765):555–6.PubMedCrossRef

11.

Santangelo AM, de Souza FS, Franchini LF, et al. Ancient exaptation of a CORE-SINE retroposon into a highly conserved mammalian neuronal enhancer of the proopiomelanocortin gene. PloS Genet. 2007;3(10):1813–26.PubMedCrossRef

12.

McClellan J, King MC. Genetic heterogeneity in human disease. Cell. 2010;141:210–7.PubMedCrossRef

13.

Klein RJ, Xu X, Mukherjee S, et al. Successes of genome-wide association studies. Cell. 2010;142:350–1. author reply 353-5.PubMedCrossRef

14.

• Miles JH. Autism spectrum disorders – a genetics review. Genet Med. 2011;13(4):278–94. An excellent, up-to-date review on autism genetics.PubMedCrossRef

15.

Jacquemont ML, Sanlaville D, Redon R, et al. Array-based comparative genomic hybridisation identifies high frequency of cryptic chromosomal rearrangements in patients with syndromic autism spectrum disorders. J Med Genet. 2006;43:843–9.PubMedCrossRef

16.

Sebat J, Lakshmi B, Malhotra D, et al. Strong association of de novo copy number mutations with autism. Science. 2007;316:445–9.PubMedCrossRef

17.

Marshall CR, Noor A, Vincent JB, et al. Structural variation of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008;82:477–88.PubMedCrossRef

18.

Glessner JT, Wang K, Cai G, et al. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature. 2009;459:569–73.PubMedCrossRef

19.

Shen Y, Dies KA, Holm IA, et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics. 2010;125(4):e727–35.PubMedCrossRef

20.

Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011;70(5):863–85.PubMedCrossRef

21.

Levy D, Ronemus M, Yamrom B, et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron. 2011;70(5):886–97.PubMedCrossRef

22.

Welberg L. Autism: The importance of getting the dose right. Nat Rev Neurosci. 2011;12(8):429.PubMedCrossRef

23.

Schaaf CP, Sabo A, Sakai Y. Oligogenic heterozygosity in individuals with high-functioning autism spectrum disorders. Hum Mol Genet. 2011;20(17):3366–75.PubMedCrossRef

24.

Leblond CS, Heinrich J, Delorme R. Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet. 2012;8(2):e1002521.PubMedCrossRef

25.

Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet. 2010;42(3):203–9.PubMedCrossRef

26.

Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009;25(12):528–35.PubMedCrossRef

27.

Sullivan PF, Magnusson C, Reichenberg A, et al. Family history of schizophrenia and bipolar disorder as risk factors for autism. Arch Gen Psychiatry. 2012;2:1–5.

28.

• Malhotra D, Sebat J. CNVs: harbingers of a rare variant revolution in psychiatric genetics. Cell. 2012;148(6):1223–41. An excellent review on the role of genetics in the etiopathogenesis of neuropsychiatric disorders.PubMedCrossRef

29.

•• Gilman SR, Iossifov I, Levy D, et al. Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses. Neuron. 2011;70(5):898–907. A bioinformatics approach to the complex landscape of autism genetics.PubMedCrossRef

30.

Pinto D, Pagnamenta AT, Klei L, et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature. 2010;466(7304):368–72.PubMedCrossRef

31.

Bourgeron T. A synaptic trek to autism. Curr Opin Neurobiol. 2009;19(2):231–4.PubMedCrossRef

32.

Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science. 2003;302(5646):826–30.PubMedCrossRef

33.

Feng J, Schroer R, Yan J, et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neurosci Lett. 2006;409(1):10–3.PubMedCrossRef

34.

Gauthier J, Siddiqui TJ, Huashan P, et al. Truncating mutations in NRXN2 and NRXN1 in autism spectrum disorders and schizophrenia. Hum Genet. 2011;130(4):563–73.PubMedCrossRef

35.

Vaags AK, Lionel AC, Sato D, et al. Rare deletions at the neurexin 3 locus in autism spectrum disorder. Am J Hum Genet. 2012;90(1):133–41.PubMedCrossRef

36.

Jamain S, Quach H, Betancur C, et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet. 2003;34(1):27–9.PubMedCrossRef

37.

Ylisaukko-oja T, Rehnström K, Auranen M, et al. Analysis of four neuroligin genes as candidates for autism. Eur J Hum Genet. 2005;13(12):1285–92.PubMedCrossRef

38.

Sato D, Lionel AC, Leblond CS, et al. SHANK1 Deletions in Males with Autism Spectrum Disorder. Am J Hum Genet. 2012;90(5):879–87.PubMedCrossRef

39.

Berkel S, Marshall CR, Weiss B, et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet. 2010;42(6):489–91.PubMedCrossRef

40.

Durand CM, Betancur C, Boeckers TM, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat Genet. 2007;39(1):25–7.PubMedCrossRef

41.

Wang X, McCoy PA, Rodriguiz RM, et al. Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet. 2011;20(15):3093–108.PubMedCrossRef

42.

Chao HT, Zoghbi HY, Rosenmund C. MeCP2 controls excitatory synaptic strength by regulating glutamatergic synapse number. Neuron. 2007;56(1):58–65.PubMedCrossRef

43.

•• Guy J, Gan J, Selfridge J, et al. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007;315(5815):1143–7. A proof-of-concept study that postnatal neurological disorders may be rescuable.

44.

Dölen G, Osterweil E, Rao BS, et al. Correction of fragile X syndrome in mice. Neuron. 2007;56(6):955–62.PubMedCrossRef

45.

Foo JN, Liu JJ, Tan EK. Whole-genome and whole-exome sequencing in neurological diseases. Nat Rev Neurol. 2012 Jul 31.

46.

Lyon GJ, Wang K. Identifying disease mutations in genomic medicine settings: current challenges and how to accelerate progress. Genome Med. 2012;4(7):58.PubMedCrossRef

47.

Majewski J, Rosenblatt DS. Exome and whole-genome sequencing for gene discovery: the future is now! Hum Mutat. 2012;33(4):591–2.PubMedCrossRef

48.

Bucan M, Abrahams BS, Wang K, et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009;5(6):e1000536.PubMedCrossRef

49.

Brunetti-Pierri N, Berg JS, Scaglia F, et al. Recurrent reciprocal 1q21.1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nat Genet. 2008;40(12):1466–71.PubMedCrossRef

50.

Schaaf CP, Boone PM, Sampath S et al. Phenotypic spectrum and genotype-phenotype correlations of NRXN1 exon deletions. Eur J Hum Genet. 2012 May 23.

51.

Willatt L, Cox J, Barber J, et al. 3q29 microdeletion syndrome: clinical and molecular characterization of a new syndrome. Am J Hum Genet. 2005;77(1):154–60.PubMedCrossRef

52.

Mervis CB, Dida J, Lam E, et al. Duplication of GTF2I results in separation anxiety in mice and humans. Am J Hum Genet. 2012;90(6):1064–70.PubMedCrossRef

53.

Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioral problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet. 2010;47(5):332–41.PubMedCrossRef

Titel: The Genetics of Autism Spectrum Disorders – A Guide for Clinicians
verfasst von: Karsten M. Heil
Christian P. Schaaf
Publikationsdatum: 01.01.2013
Verlag: Current Science Inc.
Erschienen in: Current Psychiatry Reports / Ausgabe 1/2013
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-012-0334-3

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Violence and School Shootings

Gene-Environment Studies and Borderline Personality Disorder: A Review

Components of Emotion Dysregulation in Borderline Personality Disorder: A Review